Skip to Content

Our Workshop / Mentoring

We believe in transferring knowledge, and we do it with passion! 

We excel at revealing patterns, governing forces and details that drive decision-making. Working alongside visionary leadership teams in innovative Life Sciences and High Growth / High Risk from very early research to commercial stage, we gain rare, longitudinal insight into how decisions are truly made and what drives winning pitch.  

"How did you know?" We hear that a lot.

Some call it magic wisdom or oracle sense. In truth, it’s disciplined pattern recognition—paired with the ability to zoom out to the system level and zoom in to the decisive moment, instantly and repeatedly. Early missteps in this field echo for years; once consequences surface, they are often impossible to reverse, if not, at a high cost. This dual lens is essential—for individuals, and for organizations. The earlier it is learned, the better.

Meanwhile, High Growth / High Risk dynamics and the realities of innovative Life Sciences remain poorly understood at policymaking level. Small and mid-sized ventures simply don’t have the bandwidth—or the disposition—to champion their needs to policymakers. They operate in a world governed by scarcity of time, talent, and cash, unlike large institutions with predictable inflows. As a result, the SME perspective—their insights, their brilliant ideas and their recurring frustrations —too often remains invisible. 

There is far more opportunity to outsmart the system when you understand where and how it ticks.

This is where we step in,

  1. we transfer knowledge through hands-on workshops and mentoring, designing immersive games and real cases to ensure learning that sticks.
  2. we provide a drone-like perspective of the field—commanding the big picture while detecting the specific signals that shape decisions.
  3. we take the mic or the pen on underserved topics, offering clear-eyed commentary on what we observe and, above all, the path forward.

Workshop

Workshop 

For whom?

  • Innovative ventures
  • Incubators / Accelerators
  • Tech Transfers Offices
  • Master´s programs /MBAs

Some recurrent topics : 

  • Who´s in for High Growth / High Risk?
  • Cash vs. Science : what´s driving us?
  • Value of Innovation vs. Value of  : Adoption?
  • Dealing with uncertainty
  • Cracking the innovative start-up code
  • Beyond Financial Terms
  • Value of Science (rNPV) or Value of Cash (VC model)?
  • From idea to company : early exposure to decision making and governance (term sheet + shareholder agreement negotiation)
  • In the mind and mandate of a VC
  • Pitch feedback circle
  • Market analysis from the investors´ perspective
  • How to think "Market-to-Bench"


Explore a Workshop Event together

Mentoring

Mentoring 

For whom?

  • Pre-inception teams (via incubators)
  • Young ventures
  • Mature ventures 
  • Innovative ventures shifting strategy
  • Incubator/Accelerator personnel
  • NGOs exposed to innovative Life Sciences

Some recurrent topics:

  • Strategic questions related to financing, business case, incentives, negotiation or narrative/cohesiveness designed to be addressed within 1 to 3 hours
  • Pitch deck/Valuation review
  • Equity Story vs. Investor type
  • Asset Story vs. Equity Story
  • Assessing the stage of readiness of companies, teams and assets in High Growth / High Risk at R&D stage
  • Adding the investor´s perspective to the scope of analysis/work
  • Where is cash available High Growth/High Risk, and what is it available for?
  • Where is pharma heading ? What to adjust and how?

Schedule a Mentoring Session

Round tables and panels

Roundtable & Media

For whom? 

  • BD, CRO and Biotech Associations
  • Life Sciences Conferences
  • Incubator/Accelerator Events
  • Journalists and Media professionals
  • Public bodies seeking to understand the "SME perspective"
  • NGOs and Foundations

Some topics where we were asked to share our views:

  • Financing in a changing landscape
  • R&D vs. AI, where does the value come from?
  • Real and perceived hurdles in consideration of the full value of antibiotics: How can we overcome the roadblocks?
  • How to value Innovative CROs?
  • Financing and operational challenges in infectious diseases
  • The innovative SME perspective
  • How to adjust European Capital Markets to the specific needs of innovative High Growth / High Risk ventures
  • Viability of small cap segments on stock exchanges for innovative Life Sciences ventures
  • Where is innovation and what are the gaps in AMR?

Bring a New Lens to the Conversation

Start-up Incubator

Services to incubators

Pre-inception and baby innovative High Growth / High Risk and Life Sciences companies need tailored support from incubators, dedicated initiatives and sponsors. 

We serve incubators with the same level of professionalism we bring to every part of the ecosystem. 

Working with young ventures and founders demands exceptional diligence. We help them prepare for the long game and determine if this path is right for them. Done well, this drives a steep learning curve, strong incubator differentiation, and well-invested taxpayer or sponsor money. 

It is clear to us—and to founders—that an entrepreneur-centric, growth-critical approach that starts from what truly matters to a venture’s survival and long-term trajectory delivers far greater impact than supplier-oriented models that treat start-ups as future business leads.

Policymakers aim for technological leadership with economic return. Entrepreneurs pursue a moon mission; investors seek profit. In this innovative, patent-protected field that depends on successive financing rounds, a single misstep around incorporation can derail a venture’s long-term potential 

Incubators that truly grasp the challenge beat the odds. We stand with them—and help set the benchmark.

Meet the Team Behind the Thinking